Houlihan Lokey Advises PrecisionX Group

Houlihan Lokey is pleased to announce that PrecisionX Group (PrecisionX), a portfolio company of CORE Industrial Partners (CORE), has been acquired by Windjammer Capital Investors (Windjammer).

This transaction further strengthens and highlights Houlihan Lokey’s continued leadership in the medical device outsourcing industry. Houlihan Lokey’s Healthcare Group is among the largest dedicated healthcare investment banking groups in the world. According to LSEG, in 2025, the group closed 35 transactions in the U.S. and was ranked as the No. 1 advisor for all global healthcare M&A transactions.*

Headquartered in Waterbury, Connecticut, PrecisionX offers specialty deep and shallow drawn and progressive stamping as well as Swiss screw, CNC, and wire EDM machining technologies for a variety of end markets, including aerospace and defense, medical devices, and satellite and space. The platform covers approximately 400,000 square feet of manufacturing space with more than 650 employees across seven facilities. The company holds ISO 9001, ISO 13485, and AS9100D certifications, in addition to ITAR and FDA registrations.

CORE is an industrials-focused private equity firm with more than $1.58 billion in total limited partner capital commitments across four funds investing in North American manufacturing, industrial technology, and industrial service businesses. CORE initially invested in PrecisionX in February 2023 with the vision of scaling a differentiated provider of advanced manufacturing and material science capabilities, delivering mission-critical products across highly regulated industries. Over the past three years, the company achieved nearly 5x EBITDA growth by building a robust commercial engine and investing in capacity and new capabilities, as well as executing and fully integrating five strategic add-on acquisitions.

Windjammer is a national private equity investment firm based in Newport Beach, California, and Waltham, Massachusetts, that invests control equity in middle-market businesses in partnership with management. Windjammer has more than $3 billion of committed capital with respect to its control equity investment strategy, and since inception, it has completed more than 60 platform investments and more than 200 strategic add-ons. The firm targets investments in companies that are leaders in attractive niche markets and share several of the following characteristics: significant and defensible market positions; differentiated products and services; strong management teams; scalable business models; identifiable growth opportunities; and consistent financial performance.

Windjammer plans to partner with PrecisionX’s management team to accelerate organic growth and pursue highly strategic add-on acquisitions that broaden capabilities, end-market exposure, and geographic reach. Continued investment in manufacturing technology, quality systems, and operational excellence is expected to further strengthen PrecisionX’s position as a differentiated outsourcing partner to aerospace, defense, medical device, and space customers.

Houlihan Lokey served as financial advisor to PrecisionX.

*Excludes accounting firms and brokers.

RELATED: Medical Technology, Mergers and Acquisitions